Kyle Rose
Stock Analyst
(4.10)
# 4,648
Out of 4,648 analysts
113
Total ratings
51.09%
Success rate
12.38%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Buy | $360 → $400 | $366.90 | +9.02% | 19 | Oct 30, 2024 | |
| PODD Insulet | Maintains: Buy | $226 → $234 | $237.44 | -1.45% | 15 | May 10, 2024 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $74.72 | -4.98% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $43.03 | +65.00% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $17.38 | +26.58% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.61 | +521.12% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $8.36 | +163.16% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $69.70 | +115.21% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $8.06 | +3,249.88% | 3 | May 31, 2023 | |
| SIBN SI-BONE | Maintains: Buy | $24 → $27 | $13.63 | +98.09% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.85 | +426.32% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $14.20 | +5.63% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $154.49 | -21.03% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $2.68 | +49.25% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $13.71 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $23 | $6.06 | +279.54% | 2 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $108.41 | +15.30% | 7 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $55 | $25.28 | +117.56% | 5 | Apr 30, 2021 |
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $366.90
Upside: +9.02%
Insulet
May 10, 2024
Maintains: Buy
Price Target: $226 → $234
Current: $237.44
Upside: -1.45%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $74.72
Upside: -4.98%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $43.03
Upside: +65.00%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $17.38
Upside: +26.58%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.61
Upside: +521.12%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $8.36
Upside: +163.16%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $69.70
Upside: +115.21%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $8.06
Upside: +3,249.88%
SI-BONE
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $13.63
Upside: +98.09%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $2.85
Upside: +426.32%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $14.20
Upside: +5.63%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $154.49
Upside: -21.03%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $2.68
Upside: +49.25%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $13.71
Upside: -
Mar 9, 2022
Maintains: Buy
Price Target: $25 → $23
Current: $6.06
Upside: +279.54%
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $108.41
Upside: +15.30%
Apr 30, 2021
Maintains: Buy
Price Target: $53 → $55
Current: $25.28
Upside: +117.56%